Erica L. Mayer, MD, MPH

Medical Oncology

MAKE AN APPOINTMENT

Contact Information

Office Phone Number

617-632-3800

Fax

617-632-1930

Appointments

617-632-2175

Biography

Erica L. Mayer, MD, MPH

Dr. Mayer received her medical degree from Harvard Medical School, completed her residency in Internal Medicine at Brigham and Women's Hospital, and her fellowship in Medical Oncology at the Dana-Farber Cancer Institute. She also obtained a Masters in Public Health from the Harvard School of Public Health. She joined the staff of Dana-Farber and Brigham and Women's Hospital in 2006, where she serves as Director of Breast Cancer Clinical Research. She is a breast cancer medical oncologist and clinical investigator leading research studies focused on novel therapies for the treatment of breast cancer.

Researcher

Physician

Director, Clinical Research

Institute Physician

Associate Professor of Medicine, Harvard Medical School

Centers/Programs

Breast Oncology

Clinical Interests

Breast cancer, Breast cancer in young adults

Diseases Treated

Breast Cancer

Board Certification

Internal Medicine, 2003
Medical Oncology, 2005

Fellowship

Boston Children's Hospital, Hematology/Oncology
Dana-Farber/Partners CancerCare, Hematology/Oncology

Residency

Brigham and Women's Hospital, Internal Medicine
Faulkner Hospital, Chief Medical Resident

Medical School

Harvard Medical School

Research

View Dr. Mayer’s Research

Erica Mayer, MD, MPH, is the Director of Clinical Research in the Breast Oncology Center at Dana-Farber Cancer Institute. Dr. Mayer has extensive experience leading national and global clinical trials designed to answer some of the most relevant questions in breast oncology. Her work has focused on novel agents for breast cancer, including CDK4/6 inhibitors, targeted therapies, immunotherapy, and angiogenesis inhibition. Notably, she is the global Primary Investigator of the PALLAS trial of adjuvant palbociclib. She also leads the Dana-Farber Breast Cancer in Pregnancy Program, overseeing the care and study of women diagnosed with breast cancer in pregnancy, with research focused on optimizing contemporary management for this important patient population. She has a special interest in identifying strategies to improve the tolerability and feasibility of the newest cancer therapies. Dr. Mayer has been recognized by for her skills in clinical research with the 2023 Canellos Award for Excellence in Clinical Investigation and Patient Care, and the 2024 Dana-Farber Clinical Innovation Award.

Support my research